In another study, synthetically designed complex alkaloid derivatives of carltonin A and B of the norbelladine-type were shown to exhibit anti-butyrylcholinesterase (BuChE) and -prolyl oligopeptidase (POP) properties, both of which are considered interesting targets for AD [26,27,28]. The gene discussed is PREP; the disease is Alzheimer disease.